{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:50:03Z","timestamp":1761519003214},"publisher-location":"Boston, MA","reference-count":149,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781461378372"},{"type":"electronic","value":"9781461561897"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998]]},"DOI":"10.1007\/978-1-4615-6189-7_12","type":"book-chapter","created":{"date-parts":[[2011,6,9]],"date-time":"2011-06-09T04:33:40Z","timestamp":1307594020000},"page":"209-230","source":"Crossref","is-referenced-by-count":16,"title":["Hormone replacement therapy and nonhormonal control of menopausal symptoms in breast cancer survivors"],"prefix":"10.1007","author":[{"given":"Melody A.","family":"Cobleigh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"12_CR1","first-page":"166","volume-title":"Hormone Replacement Therapy","author":"American College of Obstetricians and Gynecologists","year":"1992","unstructured":"American College of Obstetricians and Gynecologists. 1992. Hormone Replacement Therapy. Washington, DC: ACOG Technical Bulletin, April, no.166."},{"key":"12_CR2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0378-5122(92)90116-L","volume":"14","author":"I Wiklund","year":"1992","unstructured":"Wiklund I, Holst J, Karlberg J, et al. 1992. A new methodological approach to the evaluation of quality of life in postmenopausal women. Maturitas 14:211\u2013224.","journal-title":"Maturitas"},{"key":"12_CR3","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7326\/0003-4819-117-12-1016","volume":"15","author":"D Grady","year":"1992","unstructured":"Grady D, Rubin SM, Petitti DB, et al. 1992. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 15:1016\u20131037.","journal-title":"Ann Intern Med"},{"key":"12_CR4","first-page":"1861","volume":"265","author":"E Barrett-Connor","year":"1991","unstructured":"Barrett-Connor E, Bush TL. 1991. Estrogen and coronary heart disease in women. Clin Cardiol 265:1861\u20131867.","journal-title":"Clin Cardiol"},{"issue":"4","key":"12_CR5","first-page":"18S","volume":"75","author":"Editorial","year":"1990","unstructured":"Editorial. 1990. Cardiovascular implications of estrogen replacement therapy. Obstet Gynecol 75 (Suppl 4):18S\u201325S.","journal-title":"Obstet Gynecol"},{"key":"12_CR6","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM198711053171901","volume":"317","author":"DP Kiel","year":"1987","unstructured":"Kiel DP, Felson DT, Anderson JJ, et al. 1987. Hip fracture and the use of estrogens in postmenopausal women. N Engl J Med 317:1169\u20131174.","journal-title":"N Engl J Med"},{"key":"12_CR7","first-page":"27","volume":"43","author":"BA Miller","year":"1993","unstructured":"Miller BA, Feuer EJ, Hankey BF, et al. 1993. Recent incidence trends for breast cancer in women and the relevance of early detection: an update. Cancer 43:27\u201341.","journal-title":"Cancer"},{"key":"12_CR8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJM198902233200802","volume":"320","author":"B Fisher","year":"1989","unstructured":"Fisher B, Costantino J, Redmond C, et al. 1989. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogenreceptor-positive tumors. N Engl J Med 320:479\u2013484.","journal-title":"N Engl J Med"},{"key":"12_CR9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM198902233200803","volume":"320","author":"EG Mansour","year":"1989","unstructured":"Mansour EG, Gray R, Shatila AH, et al. 1989. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. N Engl J Med 320:485\u2013490.","journal-title":"N Engl J Med"},{"key":"12_CR10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM198902233200804","volume":"320","author":"The Ludwig Breast Cancer Study Group","year":"1989","unstructured":"The Ludwig Breast Cancer Study Group. 1989. Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 320:491\u2013496.","journal-title":"N Engl J Med"},{"key":"12_CR11","first-page":"474","volume":"320","author":"B Fisher","year":"1989","unstructured":"Fisher B, Redmond C, Dimitrov NV, et al. 1989. A randomized trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med 320:474\u2013478.","journal-title":"N Engl J Med"},{"key":"12_CR12","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1200\/JCO.1996.14.5.1718","volume":"14","author":"J Bines","year":"1996","unstructured":"Bines J, Oleske DM, Cobleigh MA. 1996. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14:1718\u20131729.","journal-title":"J Clin Oncol"},{"key":"12_CR13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF01834642","volume":"20","author":"RR Mehta","year":"1991","unstructured":"Mehta RR, Beattie CW, Das Gupta. 1991. Endocrine profile in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 20:125\u2013132.","journal-title":"Breast Cancer Res Treat"},{"key":"12_CR14","first-page":"227","volume-title":"Adjuvant Therapy of Cancer II","author":"G Bonadonna","year":"1979","unstructured":"Bonadonna G, Valagussa P, Rossi A, et al. 1979. CMF adjuvant chemotherapy in operable breast cancer. In Jones SE, Salmon SS, eds. Adjuvant Therapy of Cancer II. New York: Grune and Stratton, pp. 227\u2013235."},{"key":"12_CR15","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM199109123251102","volume":"325","author":"MJ Stampfer","year":"1991","unstructured":"Stampfer MJ, Colditz GA, Willett WC, et al. 1991. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses\u2019 Health Study. N Engl J Med 325:756\u2013762.","journal-title":"N Engl J Med"},{"key":"12_CR16","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1200\/JCO.1993.11.11.2090","volume":"11","author":"PP Rosen","year":"1993","unstructured":"Rosen PP, Groshen S, Kinne DW, et al. 1993. Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1NOMO\/T2NOMO patients with long-term follow-up. J Clin Oncol 11:2090\u20132100.","journal-title":"J Clin Oncol"},{"key":"12_CR17","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/jama.267.4.568b","volume":"267","author":"JM Merill","year":"1992","unstructured":"Merill JM. 1992. Questions and answers. Estrogen replacement therapy after breast cancer. JAMA 267:568.","journal-title":"JAMA"},{"key":"12_CR18","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00006250-199102000-00031","volume":"77","author":"WT Creasman","year":"1991","unstructured":"Creasman WT. 1991. Estrogen replacement therapy: is previously treated cancer a contraindication? Obstet Gynecol 77:308\u2013311.","journal-title":"Obstet Gynecol"},{"key":"12_CR19","first-page":"607","volume":"64","author":"KA Hutchinson-Williams","year":"1991","unstructured":"Hutchinson-Williams KA, et al. 1991. Yale J Biol Med 64:607\u2013626.","journal-title":"Yale J Biol Med"},{"key":"12_CR20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/oxfordjournals.annonc.a057847","volume":"2","author":"RL Theriault","year":"1991","unstructured":"Theriault RL, Sellin RV. 1991. A clinical dilemma: estrogen replacement therapy in postmenopausal women with a background of primary breast cancer. Ann Oncol 2:709\u2013717.","journal-title":"Ann Oncol"},{"key":"12_CR21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5694\/j.1326-5377.1992.tb137283.x","volume":"157","author":"JA Davidson","year":"1991","unstructured":"Davidson JA. 1991. The need for a randomized trial of hormone replacement therapy in women with breast cancer. Med J Aust 157:429.","journal-title":"Med J Aust"},{"key":"12_CR22","first-page":"129","volume":"150","author":"PJ DiSaia","year":"1984","unstructured":"DiSaia PJ. 1984. Invited discussion. Am J Obstet Gynecol 150:129.","journal-title":"Am J Obstet Gynecol"},{"key":"12_CR23","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/1097-0142(19930315)71:6+<2127::AID-CNCR2820711602>3.0.CO;2-2","volume":"71","author":"IC Henderson","year":"1993","unstructured":"Henderson IC. 1993. Risk factors for development of breast cancer. Cancer (Suppl) 71:2127\u20132140.","journal-title":"Cancer"},{"key":"12_CR24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5694\/j.1326-5377.1992.tb137081.x","volume":"157","author":"JA Eden","year":"1992","unstructured":"Eden JA. 1992. General practice, common problems: oestrogen and the breast. 1. Myths about oestrogen and breast cancer. Med J Aust 157:175\u2013176.","journal-title":"Med J Aust"},{"issue":"8597","key":"12_CR25","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0140-6736(88)92096-X","volume":"1","author":"BA Stoll","year":"1988","unstructured":"Stoll BA, Parbhoo S. 1988. Treatment of menopausal symptoms in breast cancer patients. Lancet 1(8597):1278\u20131279.","journal-title":"Lancet"},{"key":"12_CR26","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/1097-0142(19930315)71:6+<2169::AID-CNCR2820711608>3.0.CO;2-B","volume":"71","author":"DJ Marchant","year":"1993","unstructured":"Marchant DJ. 1993. Estrogen-replacement therapy after breast cancer. Cancer 71:2169\u20132176.","journal-title":"Cancer"},{"key":"12_CR27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5694\/j.1326-5377.1992.tb137129.x","volume":"157","author":"J Eden","year":"1992","unstructured":"Eden J. 1992. General practice, common problems: oestrogen and the breast. 2. The management of the menopausal woman with breast cancer. Med J Aust 157:247\u2013250.","journal-title":"Med J Aust"},{"key":"12_CR28","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/0277-5379(89)90372-6","volume":"25","author":"A Stoll","year":"1989","unstructured":"Stoll A. 1989. Hormone replacement therapy in women treated for breast cancer. Eur J Cancer Clin Oncol 25:1909.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"12_CR29","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.7326\/0003-4819-117-12-1038","volume":"117","author":"American College of Physicians","year":"1992","unstructured":"American College of Physicians. 1992. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med 117:1038\u20131041.","journal-title":"Ann Intern Med"},{"key":"12_CR30","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1161\/01.CIR.88.4.1999","volume":"88","author":"ED Eaker","year":"1993","unstructured":"Eaker ED, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP, Winston M. 1993. Cardiovascular disease in women. Circulation 88:1900\u20132009.","journal-title":"Circulation"},{"key":"12_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0140-6736(92)90997-H","volume":"339","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"1992","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group. 1992. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339:1\u201315.","journal-title":"Lancet"},{"issue":"8706","key":"12_CR32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0140-6736(90)91555-O","volume":"336","author":"TJ Powles","year":"1990","unstructured":"Powles TJ. 1990. Tamoxifen and oestrogen replacement. Lancet 336(8706):48.","journal-title":"Lancet"},{"key":"12_CR33","first-page":"949","volume":"79","author":"VL Ernster","year":"1987","unstructured":"Ernster VL, Wrensch MR, Petrakis NL, King EB, Miike R, Mural J, Goodson WH III, Siiteri PK. 1987. Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens. J Natl Cancer Inst 79:949\u2013960.","journal-title":"J Natl Cancer Inst"},{"key":"12_CR34","first-page":"624","volume":"47","author":"VC Jordan","year":"1987","unstructured":"Jordan VC, Fritz NF, Tormey DC. 1987. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer. Cancer Res 47:624\u2013630.","journal-title":"Cancer Res"},{"key":"12_CR35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01805972","volume":"14","author":"TJ Powles","year":"1989","unstructured":"Powles TJ, Hardy JR, Ashley SE, et al. 1989. Chemo-prevention of breast cancer. Breast Cancer Res Treat 14:23\u201331.","journal-title":"Breast Cancer Res Treat"},{"key":"12_CR36","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1172\/JCI109475","volume":"64","author":"BM Sherman","year":"1979","unstructured":"Sherman BM, Chapler FK, Crickard K, et al. 1979. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women. J Clin Invest 64:398\u2013404.","journal-title":"J Clin Invest"},{"key":"12_CR37","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1200\/JCO.1991.9.7.1283","volume":"9","author":"MC Sunderland","year":"1991","unstructured":"Sunderland MC, Osborne CK. 1991. Tamoxifen in premenopausal patients with metastatic breast cancer: a review. J Clin Oncol 9:1283\u20131297.","journal-title":"J Clin Oncol"},{"key":"12_CR38","first-page":"A70","volume":"9","author":"M Pollack","year":"1990","unstructured":"Pollack M, Polychronakos C, Blauer S, et al. 1990. Effect of tamoxifen on serum insulin-like growth factor I (IGF-I) levels of stae I breast cancer patients. Proc Annu Meet Am Soc Clin Oncol 9:A70.","journal-title":"Proc Annu Meet Am Soc Clin Oncol"},{"key":"12_CR39","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/0006-291X(87)90819-9","volume":"146","author":"F Vignon","year":"1987","unstructured":"Vignon F, Bouton M-M, Rochefort H. 1987. Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun 146:1502\u20131508.","journal-title":"Biochem Biophys Res Commun"},{"key":"12_CR40","first-page":"2462","volume":"45","author":"CA O\u2019Brien","year":"1985","unstructured":"O\u2019Brien CA, Liskamp RM, Solomon DH, et al. 1985. Inhibition of protein kinase C by tamoxifen. Cancer Res 45:2462\u20132465.","journal-title":"Cancer Res"},{"key":"12_CR41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0006-291X(84)91062-3","volume":"118","author":"H-YP Lam","year":"1984","unstructured":"Lam H-YP. 1984. Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase. Biochem Biophys Res Commun 118:27\u201332.","journal-title":"Biochem Biophys Res Commun"},{"key":"12_CR42","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1200\/JCO.1985.3.12.1672","volume":"3","author":"V Hug","year":"1985","unstructured":"Hug V, Hortobagyi GN, Drewinka B, et al. 1985. Tamoxifen-citrate counteracts the antitumor effects of cytotoxic drugs in vitro. J Clin Oncol 3:1672\u20131677.","journal-title":"J Clin Oncol"},{"key":"12_CR43","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/0277-5379(84)90174-3","volume":"20","author":"R Mandeville","year":"1984","unstructured":"Mandeville R, Ghali SS, Chausseau J-P. 1984. In vitro stimulation of human NK activity by an estrogen antagonist (tamoxifen). Eur J Cancer Clin Oncol 20:983\u2013985.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"12_CR44","first-page":"1463","volume":"60","author":"JC Heuson","year":"1976","unstructured":"Heuson JC. 1976. Current overview of EORTC clinical trials with tamoxifen. Cancer Treat Rep 60:1463\u20131466.","journal-title":"Cancer Treat Rep"},{"key":"12_CR45","first-page":"779","volume":"64","author":"A Manni","year":"1980","unstructured":"Manni A, Pearson OH. 1980. Antiestrogen-induced remissions in premenopausal women with stage IV breast cancer: effects on ovarian function. Cancer Treat Rep 64:779\u2013785.","journal-title":"Cancer Treat Rep"},{"key":"12_CR46","first-page":"3152","volume":"46","author":"CA Sawka","year":"1986","unstructured":"Sawka CA, Pritchard KI, Paterson AHG, et al. 1986. Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma. Cancer Res 46:3152\u20133156.","journal-title":"Cancer Res"},{"key":"12_CR47","first-page":"787","volume":"64","author":"KI Pritchard","year":"1980","unstructured":"Pritchard KI, Thomson DB, Myers RE, et al. 1980. Tamoxifen therapy in premenopausal patients with metastatic breast cancer. Cancer Treat Rep 64:787\u2013796.","journal-title":"Cancer Treat Rep"},{"key":"12_CR48","first-page":"728","volume":"65","author":"T Wada","year":"1981","unstructured":"Wada T, Koyama H, Terasawa T. 1981. Effect of tamoxifen in premenopausal Japanese women with advanced breast cancer. Cancer Treat Rep 65:728\u2013729.","journal-title":"Cancer Treat Rep"},{"key":"12_CR49","first-page":"57","volume":"12","author":"M Yoshida","year":"1982","unstructured":"Yoshida M, Murai H, Miura S. 1982. Tamoxifen therapy for premenopausal and postmenopausal Japanese females with advanced breast cancer. Jpn J Clin Oncol 12:57\u201364.","journal-title":"Jpn J Clin Oncol"},{"key":"12_CR50","first-page":"4788","volume":"42","author":"B Hoogstraten","year":"1982","unstructured":"Hoogstraten B, Fletcher WS, Grad-el-Mawia N, et al. 1982. Tamoxifen and oophorectomy in the treatment of recurrent breast cancer. A Southwest Oncology Group study. Cancer Res 42:4788\u20134791.","journal-title":"Cancer Res"},{"key":"12_CR51","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/1097-0142(19841115)54:10<2248::AID-CNCR2820541031>3.0.CO;2-D","volume":"54","author":"B Hoogstraten","year":"1984","unstructured":"Hoogstraten B, Gad-el-Mawla N, Maloney TR, et al. 1984. Combined modality therapy for first recurrence of breast cancer. A Southwest Oncology Group study. Cancer 54:2248\u20132256.","journal-title":"Cancer"},{"key":"12_CR52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF01806987","volume":"4","author":"R Margrieter","year":"1984","unstructured":"Margrieter R, Wiegele J. 1984. Tamoxifen for premenopausal patients with advanced breast cancer. Cancer Res Treat 4:45\u201349.","journal-title":"Cancer Res Treat"},{"key":"12_CR53","first-page":"363","volume":"69","author":"AST Planting","year":"1985","unstructured":"Planting AST, Alexieva-Figusch J, Blonk-v.d. Wijst J, et al. 1985. Tamoxifen therapy in premenopausal women with metastatic breast cancer. Cancer Treat Rep 69:363\u2013368.","journal-title":"Cancer Treat Rep"},{"key":"12_CR54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF01833329","volume":"22","author":"RF Krywicki","year":"1992","unstructured":"Krywicki RF, Yee D. 1992. The insulin-like growth family family of ligands, receptors and binding proteins. Breast Cancer Res Treat 22:7\u201319.","journal-title":"Breast Cancer Res Treat"},{"key":"12_CR55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF01833334","volume":"22","author":"JP Peyrat","year":"1992","unstructured":"Peyrat JP, Bonneterre J. 1992. Type I IGF receptor in human breast diseases. Breast Cancer Res Treat 22:59\u201367.","journal-title":"Breast Cancer Res Treat"},{"key":"12_CR56","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0006-291X(88)90688-2","volume":"154","author":"MN Pollak","year":"1988","unstructured":"Pollak MN, Polychronakos C, Yousefi S, et al. 1988. Characterization of insulin-like growth factor (IGF-1) receptors of human breast cancer cells. Biochem Biophys Res Commun 154:326\u2013331.","journal-title":"Biochem Biophys Res Commun"},{"key":"12_CR57","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0960-0760(92)90379-W","volume":"41","author":"T Thorsen","year":"1992","unstructured":"Thorsen T, Lahooti H, Rasmussen M, et al. 1992. Oestradiol treatment increases the sensitivity of MCF-7 cells for the growth stimulatory effect of IGF-I. J Steroid Biochem Mol Biol 41:537\u2013540.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"12_CR58","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/0006-291X(87)90819-9","volume":"146","author":"F Vignon","year":"1987","unstructured":"Vignon F, Bouton MM, Rochefort H. 1987. Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun 146:1502\u20131508.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"12_CR59","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/0959-8049(93)90003-X","volume":"29A","author":"A Friedl","year":"1993","unstructured":"Friedl A, Jordan VC, Pollak M. 1993. Suppression of serum insulin-like growth factor-1 levels in breast cancer patients during adjuvant tamoxifen therapy. Eur J Cancer 29A(10):1368\u20131372.","journal-title":"Eur J Cancer"},{"key":"12_CR60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1200\/JCO.1994.12.1.155","volume":"12","author":"RM Goldberg","year":"1994","unstructured":"Goldberg RM, Loprinzi CL, O\u2019Fallon JR, Veeder MH, Miser AW, Mailliard JA, Michalak JC, Dose A, Rowland KM, Burnham NL. 1994. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol 12:155\u2013158.","journal-title":"J Clin Oncol"},{"key":"12_CR61","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF00542092","volume":"20","author":"BI Nesheim","year":"1981","unstructured":"Nesheim BI, Saetre T. 1981. Reduction of menopausal hot flushes by methyldopa. Eur J Clin Pharmacol 20:413\u2013416.","journal-title":"Eur J Clin Pharmacol"},{"key":"12_CR62","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0378-5122(81)90008-6","volume":"3","author":"Y Erik","year":"1981","unstructured":"Erik Y, Meldrum DR, Lagasse LD, Judd HL. 1981. Effect of megestrol acetate on flushing and bone metabolism in postmenopausal women. Maturitas 3:167\u2013172.","journal-title":"Maturitas"},{"key":"12_CR63","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM199408113310602","volume":"331","author":"CL Loprinzi","year":"1994","unstructured":"Loprinzi CL, Michalak JC, Quella SK, et al. 1994. Megestrol acetate for the prevention of hot flashes. N Engl J Med 331:347\u2013352.","journal-title":"N Engl J Med"},{"key":"12_CR64","first-page":"165","volume":"46","author":"JL Bullock","year":"1975","unstructured":"Bullock JL, Massey FM, Cambrell RD Jr. 1975. Use of medroxyprogesterone acetate to prevent menopausal symptoms. Obstet Gynecol 46:165\u2013168.","journal-title":"Obstet Gynecol"},{"key":"12_CR65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0002-9378(80)90017-4","volume":"138","author":"JC Morrison","year":"1980","unstructured":"Morrison JC, Martin DC, Blair RA, et al. 1980. The use of medroxyprogesterone acetate for relief of climacteric symptoms. Am J Obstet Gynecol 138:99\u2013104.","journal-title":"Am J Obstet Gynecol"},{"key":"12_CR66","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0002-9378(81)90475-0","volume":"139","author":"BG Albrecht","year":"1981","unstructured":"Albrecht BG, Schiff I, Tulchinsky D, Ryan KJ. 1981. Objective evidence that placebo and oral medroxyprogesterone acetate therapy diminish menopausal valomotor flushes. Am J Obstet Gynecol 139:631\u2013635.","journal-title":"Am J Obstet Gynecol"},{"key":"12_CR67","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2165\/00003495-199040020-00004","volume":"40","author":"RL Young","year":"1990","unstructured":"Young RL, Kumar NS, Goldzieher JW. 1990. Management of menopause when estrogen cannot be used. Drugs 40:220\u2013230.","journal-title":"Drugs"},{"key":"12_CR68","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jama.1980.03310130021021","volume":"244","author":"I Schiff","year":"1980","unstructured":"Schiff I, Tuschinsky D, Cramer D. 1980. Oral medroxyprogesterone acetate in the treatment of postmenopausal symtoms. JAMA 244:1443\u20131445.","journal-title":"JAMA"},{"key":"12_CR69","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0378-5122(87)90005-3","volume":"9","author":"MGM Bergmans","year":"1987","unstructured":"Bergmans MGM, Merkus JMWM, Corbey RS, Schellekens LA, Ubach JM. 1987. Effect of bellergal Retard on climacteric complaints: a double-blind, placebo-controlled study. Maturitas 9:227\u2013234.","journal-title":"Maturitas"},{"key":"12_CR70","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00000478-198606000-00003","volume":"10","author":"TA Longacre","year":"1986","unstructured":"Longacre TA, Bartow SA. 1986. A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 10:382\u2013393.","journal-title":"Am J Surg Pathol"},{"key":"12_CR71","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/bjc.1988.185","volume":"58","author":"CS Potten","year":"1988","unstructured":"Potten CS, Watson RJ, Williams GT, Tickle S, Roberts SA, Harris M, Howell A. 1988. The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 58:163\u2013170.","journal-title":"Br J Cancer"},{"key":"12_CR72","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0046-8177(89)80003-6","volume":"20","author":"TJ Anderson","year":"1989","unstructured":"Anderson TJ, Battersby S, King RJB, McPherson K, Going JJ. 1989. Oral contraceptive use influences resting breast proliferation. Hum Pathol 20:1139\u20131144.","journal-title":"Hum Pathol"},{"key":"12_CR73","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/oxfordjournals.aje.a115328","volume":"130","author":"L Bergkvist","year":"1992","unstructured":"Bergkvist L, Adami Ho, Person I, et al. 1992. Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol 130:221\u2013228.","journal-title":"Am J Epidemiol"},{"key":"12_CR74","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1126\/science.137.3526.257","volume":"137","author":"C Huggins","year":"1962","unstructured":"Huggins C, Yang NC. 1962. Induction and extinction of mammary cancer. Science 137:257\u2013262.","journal-title":"Science"},{"key":"12_CR75","first-page":"225","volume":"46","author":"JE Diamond","year":"1979","unstructured":"Diamond JE, Hollander VP. 1979. Progesterone and breast cancer. Mt Sinai J Med 46:225\u2013235.","journal-title":"Mt Sinai J Med"},{"key":"12_CR76","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/jnci\/83.7.492","volume":"83","author":"VC Jordan","year":"1991","unstructured":"Jordan VC, MK, Langan-Fahey S. 1991. Suppression of mouse mammary tumorigenesis by long term tamoxifen therapy. J Natl Cancer Inst 83:492\u2013496.","journal-title":"J Natl Cancer Inst"},{"key":"12_CR77","first-page":"33","volume-title":"Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate","author":"E Kordon","year":"1990","unstructured":"Kordon E, Lanari C, Meiss R, Elizalde P, Charreau E, Pasqualini CD. 1990. Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate. Breast Cancer Res Treat 33\u201343."},{"key":"12_CR78","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/0006-291X(87)91022-9","volume":"45","author":"JR Hissom","year":"1987","unstructured":"Hissom JR, Moore MR. 1987. Progestin effects on growth in the human breast cancer cell line T47D. Possible therapeutic implications. Biochem Biophys Res Commun 45:706\u2013711.","journal-title":"Biochem Biophys Res Commun"},{"key":"12_CR79","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0304-3835(86)90091-1","volume":"30","author":"H Braunsberg","year":"1986","unstructured":"Braunsberg H, Coldham NG, Wong W. 1986. Hormonal therapies for breast cancer: can progestogens stimulate growth? Cancer Let 30:213\u2013218.","journal-title":"Cancer Let"},{"key":"12_CR80","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","volume":"273","author":"The Writing Group for the PEPI trial","year":"1995","unstructured":"The Writing Group for the PEPI trial. 1995. Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 273:199\u2013208.","journal-title":"JAMA"},{"key":"12_CR81","first-page":"171","volume":"63","author":"HT Mouridsen","year":"1979","unstructured":"Mouridsen HT, Elleman K, Mattsson W. 1979. Therapeuic effect of tamoxifen vs tamoxifen combined with medroxyprogesterone acetate in advanced breast cancer in postmenopausal women. Cancer Treat Rep 63:171\u2013175.","journal-title":"Cancer Treat Rep"},{"key":"12_CR82","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00665699","volume":"27","author":"DFC Gibson","year":"1993","unstructured":"Gibson DFC, Johnson DA, Langan-Fahey SM, Lababidi MK, Wolberg WH, Jordan VC. 1993. The effects of intermittent progesterone upon tamoxifen inhibition of tumor growth in the 7,12-dimethylbenzanthracene rat mammary tumor model. Breast Cancer Res and Treat 27:283\u2013287.","journal-title":"Breast Cancer Res and Treat"},{"key":"12_CR83","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0015-0282(16)43511-9","volume":"30","author":"I Schiff","year":"1978","unstructured":"Schiff I, Wentworth B, Koos B, Tulchinsky D, Ryan KJ. 1978. Effect of estriol administration on the hypogonadal woman. Fertil Steril 30:278\u2013282.","journal-title":"Fertil Steril"},{"key":"12_CR84","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/00016348309154208","volume":"62","author":"LA Mattsson","year":"1983","unstructured":"Mattsson LA, Cullberg G. 1983. Vaginal absorption of two estriol preparations. Asta Obstet Gynecol Scand 62:393\u2013396.","journal-title":"Asta Obstet Gynecol Scand"},{"key":"12_CR85","first-page":"23","volume":"139","author":"GM Heimer","year":"1987","unstructured":"Heimer GM. 1987. Estriol in the menopause. Acta Obstet Gynecol Scand Suppl 139:23P.","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"12_CR86","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0015-0282(16)56474-7","volume":"61","author":"LE Nachtigall","year":"1994","unstructured":"Nachtigall LE. 1994. Comparative study: Replens versus local estrogen in menopausal women. Fertil Steril 61:178\u2013180.","journal-title":"Fertil Steril"},{"key":"12_CR87","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0378-5122(89)90213-2","volume":"11","author":"LA Mattsson","year":"1989","unstructured":"Mattsson LA, Cullberg G, Eriksson O, Knutsson F. 1989. Vaginal administration of low-dose estradiol - effects on the endometrium and vaginal cytology. Maturitas 11:217\u2013222.","journal-title":"Maturitas"},{"key":"12_CR88","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0378-5122(94)90050-7","volume":"18","author":"J Rymer","year":"1994","unstructured":"Rymer J, Chapman MG, Fogelman I, Wilson POG. 1994. A study of the effect of tibolone on the vagina in postmenopausal women. Maturitas 18:127\u2013133.","journal-title":"Maturitas"},{"key":"12_CR89","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM199203263261302","volume":"326","author":"RR Love","year":"1992","unstructured":"Love RR, Mazess RB, Barden HS, et al. 1992. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 326:852\u2013856.","journal-title":"N Engl J Med"},{"key":"12_CR90","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7326\/0003-4819-120-2-199401150-00001","volume":"120","author":"JF Aloia","year":"1994","unstructured":"Aloia JF, Vaswani A, Yeh JK, et al. 1994. Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann Intern Med 120:97\u2013103.","journal-title":"Ann Intern Med"},{"key":"12_CR91","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/jnci\/82.16.1327","volume":"82","author":"RR Love","year":"1990","unstructured":"Love RR, Newcomb PA, Wiebe DA, Surawicz TS, Jorhan VC, Carbone PP, DeMets DL. 1990. Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer. J Natl Cancer Inst 82:1327\u20131332.","journal-title":"J Natl Cancer Inst"},{"key":"12_CR92","doi-asserted-by":"crossref","first-page":"860","DOI":"10.7326\/0003-4819-115-11-860","volume":"115","author":"RR Love","year":"1991","unstructured":"Love RR, Wiebe DA, Newcomb PA, Cameron L, Leventhal H, Jorhan VC, Feyzi J, DeMets. 1991. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women. Ann Intern Med 115:860\u2013864.","journal-title":"Ann Intern Med"},{"key":"12_CR93","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0002-9343(92)90077-O","volume":"92","author":"M Devor","year":"1992","unstructured":"Devor M, Barrett-Connor E, Ranvall M, et al. 1992. Estrogen replacement therapy and the risk of venous thrombosis. Am J Med 92:275\u2013282.","journal-title":"Am J Med"},{"key":"12_CR94","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJM197512042932302","volume":"293","author":"DC Smith","year":"1975","unstructured":"Smith DC, Prentice R, Donovan JT, et al. 1975. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 293:1164\u20131167.","journal-title":"N Engl J Med"},{"key":"12_CR95","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bjc.1983.127","volume":"47","author":"BE Henderson","year":"1983","unstructured":"Henderson BE, Casagrande JT, Pike MC, et al. 1983. The epidemiology of endometrial cancer in young women. Br J Cancer 47:749\u2013756.","journal-title":"Br J Cancer"},{"key":"12_CR96","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(89)91141-0","volume":"1","author":"T Fornander","year":"1989","unstructured":"Fornander T, Rutqvist LE, Cedermark B, et al. 1989. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1:117\u2013120.","journal-title":"Lancet"},{"key":"12_CR97","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1148\/radiology.174.1.2152982","volume":"174","author":"JE Berkowitz","year":"1990","unstructured":"Berkowitz JE, Gatewood OM, Goldblum LE, et al. 1990. Hormonal replacement therapy: mammographie manifestations. Radiology 174:199\u2013201.","journal-title":"Radiology"},{"key":"12_CR98","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0009-9260(05)80566-5","volume":"43","author":"Z Kaufman","year":"1991","unstructured":"Kaufman Z, Garstin WI, Hayes R, et al. 1991. The mammographie parenchymal patterns of women on hormonal replacement therapy. Clin Radiol 43:389\u2013392.","journal-title":"Clin Radiol"},{"key":"12_CR99","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1002\/1097-0142(19800615)45:12<3027::AID-CNCR2820451225>3.0.CO;2-2","volume":"45","author":"KI Bland","year":"1980","unstructured":"Bland KI, Buchanan JB, Weisberg BF, et al. 1980. The effects of exogenous estrogen replacement therapy of the breast: breast cancer risk and mammographie parenchymal patterns. Cancer 45:3027\u20133033.","journal-title":"Cancer"},{"key":"12_CR100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1148\/radiology.174.2.2136958","volume":"174","author":"PC Stomper","year":"1990","unstructured":"Stomper PC, Van Voorhis BJ, Ravnikar VA, et al. 1990. Mammographie changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology 174:487\u2013490.","journal-title":"Radiology"},{"key":"12_CR101","first-page":"5615","volume":"48","author":"JL Kelsey","year":"1988","unstructured":"Kelsey JL, Berkowitz GS. 1988. Breast cancer epidemiology. Cancer Res 48:5615\u20135623.","journal-title":"Cancer Res"},{"key":"12_CR102","first-page":"85","volume-title":"Multiple primary cancers in Connecticut and Denmark","author":"EB Harvey","year":"1985","unstructured":"Harvey EB, Brinton LA. 1985. Second cancer following cancer of the breast in Connecticut, 1935\u20131982. In Boice JD Jr, Storm HH, Curtis RE, eds. Multiple primary cancers in Connecticut and Denmark. National Cancer Institute Monograph 68. Washington, DC: Government Printing Office, pp. 99\u2013112 (NIH publication no. 85\u20132714)."},{"key":"12_CR103","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1471-0528.1987.tb03166.x","volume":"94","author":"K Hunt","year":"1987","unstructured":"Hunt K, Vessey M, McPherson K, Coleman M. 1987. Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynecol 94:620\u2013635.","journal-title":"Br J Obstet Gynecol"},{"key":"12_CR104","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/oxfordjournals.aje.a116042","volume":"134","author":"JR Palmer","year":"1991","unstructured":"Palmer JR, Rosenbert L, Clarkey EA, et al. 1991. Breast cancer risk after estrogen replacement therapy: results from the Toronto Breast Cancer Society. Am J Epidemiol 134:1386\u20131395.","journal-title":"Am J Epidemiol"},{"key":"12_CR105","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/1097-0142(19890301)63:5<948::AID-CNCR2820630527>3.0.CO;2-U","volume":"643","author":"WD DuPont","year":"1989","unstructured":"DuPont WD, Page DL, Roges LW, et al. 1989. Influence of exogenous estrogens, proliferative breast disease and other variables on breast cancer risk. Cancer 643:948\u2013957.","journal-title":"Cancer"},{"key":"12_CR106","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1001\/archinte.1988.00380010142014","volume":"148","author":"RC Brownson","year":"1988","unstructured":"Brownson RC, Blackwell CW, Pearson DK, et al. 1988. Risk of breast cancer relation to cigarette smoking. Arch Intern Med 148:140\u2013144.","journal-title":"Arch Intern Med"},{"key":"12_CR107","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5694\/j.1326-5377.1988.tb99427.x","volume":"148","author":"TE Rohan","year":"1988","unstructured":"Rohan TE, McMichael AJ. 1988. Non-contraceptive exogenous oestrogen therapy and breast cancer. Med J Aust 148:217\u2013221.","journal-title":"Med J Aust"},{"key":"12_CR108","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jama.1987.03390020075030","volume":"257","author":"PO Wingo","year":"1987","unstructured":"Wingo PO, Layde PM, Lee NC, et al. 1987. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. JAMA 257:209\u2013215.","journal-title":"JAMA"},{"key":"12_CR109","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/oxfordjournals.aje.a114632","volume":"125","author":"JE Buring","year":"1987","unstructured":"Buring JE, Hennekens CH, Lipnick RJ. 1987. A prospective cohort study of postmenopausal hormone use and risk of breast cancer in US women. Am J Epidemiol 125:939\u2013947.","journal-title":"Am J Epidemiol"},{"key":"12_CR110","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/bjc.1986.246","volume":"54","author":"LA Brinton","year":"1986","unstructured":"Brinton LA, Hoover R, Fraumeni JF Jr. 1986. Menopausal oestrogens and breast cancer risk: an expanded case-control study. Br J Cancer 54:825\u2013832.","journal-title":"Br J Cancer"},{"key":"12_CR111","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ijc.2910370109","volume":"37","author":"AM Nomura","year":"1986","unstructured":"Nomura AM, Kolonel LN, Hirohata T, et al. 1986. The association of replacement estrogens with breast cancer. Int J Cancer 37:49\u201353.","journal-title":"Int J Cancer"},{"key":"12_CR112","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0002-9343(84)90773-3","volume":"76","author":"RI Horwitz","year":"1984","unstructured":"Horwitz RI, Stewart KR. 1984. Effect of clinical features on the association of estrogens and breast cancer. Am J Med 76:192\u2013198.","journal-title":"Am J Med"},{"key":"12_CR113","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.1984.03350010029018","volume":"252","author":"DW Kaufman","year":"1984","unstructured":"Kaufman DW, Miller DR, Rosenberg L, et al. 1984. Noncontraceptive estrogen use and the risk of breast cancer. JAMA 252:63\u201367.","journal-title":"JAMA"},{"key":"12_CR114","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/1097-0142(19840701)54:1<139::AID-CNCR2820540128>3.0.CO;2-X","volume":"54","author":"RA Hiatt","year":"1984","unstructured":"Hiatt RA, Bawol R, Friedman GD, et al. 1984. Exogenous estrogen and breast cancer after bilateral oophorectomy. Cancer 54:139\u2013144.","journal-title":"Cancer"},{"key":"12_CR115","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/1097-0142(19830415)51:8<1527::AID-CNCR2820510828>3.0.CO;2-T","volume":"51","author":"B Sherman","year":"1983","unstructured":"Sherman B, Wallace R, Bean J. 1983. Estrogen use and breast cancer: interaction with body mass. Cancer 51:1527\u20131531.","journal-title":"Cancer"},{"key":"12_CR116","first-page":"435","volume":"62","author":"RD Gambrell","year":"1983","unstructured":"Gambrell RD, Maier RC, Sanders BI. 1983. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users. Obstet Gynecol 62:435\u2013443.","journal-title":"Obstet Gynecol"},{"key":"12_CR117","first-page":"327","volume":"67","author":"JL Kelsey","year":"1981","unstructured":"Kelsey JL, Fischer DB, Holford TR, et al. 1981. Exogenous estrogens and other factors in the epidemiology of breast cancer. J Natl Cancer Inst 67:327\u2013333.","journal-title":"J Natl Cancer Inst"},{"key":"12_CR118","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/oxfordjournals.aje.a116041","volume":"134","author":"DW Kaufman","year":"1991","unstructured":"Kaufman DW, Palmer JR, deMouzon J, et al. 1991. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study. Am J Epidemiol 134:1375\u20131385.","journal-title":"Am J Epidemiol"},{"key":"12_CR119","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1001\/jama.1990.03450200056031","volume":"264","author":"GA Colditz","year":"1990","unstructured":"Colditz GA, Stampfer MJ, Willett WC, et al. 1990. Prospective study of estrogen replacement therapy and risk of breast cancer in pmp women. JAMA 264:2648\u20132653.","journal-title":"JAMA"},{"key":"12_CR120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM198908033210505","volume":"321","author":"L Bergkvist","year":"1989","unstructured":"Bergkvist L, Adami HO, Person I, et al. 1989. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 321:293\u2013297.","journal-title":"N Engl J Med"},{"key":"12_CR121","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/1097-0142(19890801)64:3<591::AID-CNCR2820640305>3.0.CO;2-U","volume":"64","author":"PK Mills","year":"1989","unstructured":"Mills PK, Beeson WL, Phillips RL, et al. 1989. Prospective study of exogenous hormone use and breast cancer in Seventh-Day Adventists. Cancer 64:591\u2013597.","journal-title":"Cancer"},{"key":"12_CR122","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ijc.2910420606","volume":"42","author":"M Ewertz","year":"1988","unstructured":"Ewertz M. 1988. Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark. Int J Cancer 42:832\u2013838.","journal-title":"Int J Cancer"},{"key":"12_CR123","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0002-9378(82)90108-9","volume":"143","author":"BS Hulka","year":"1982","unstructured":"Hulka BS, Chambless LE, Deubner DC, et al. 1982. Breast cancer and estrogen replacement therapy. Am J Obstet Gynecol 143:638\u2013644.","journal-title":"Am J Obstet Gynecol"},{"key":"12_CR124","first-page":"1017","volume":"69","author":"DB Thomas","year":"1982","unstructured":"Thomas DB, Persing JP, Hutchinson WB. 1982. Exogenous estrogens and other risk factors for breast cancer in women with benign breast diseases. J Natl Cancer Inst 69:1017\u20131025.","journal-title":"J Natl Cancer Inst"},{"key":"12_CR125","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/jnci\/67.4.889","volume":"67","author":"R Hoover","year":"1981","unstructured":"Hoover R, Glass A, Finkle WD, et al. 1981. Conjugated estrogens and breast cancer risk in women. J Natl Cancer Inst 67:815\u2013820.","journal-title":"J Natl Cancer Inst"},{"key":"12_CR126","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/jama.1980.03300420019018","volume":"243","author":"RK Ross","year":"1980","unstructured":"Ross RK, Paganini-Hill, Gerkins VR, et al. 1980. A case-control study of menopausal estrogen therapy and breast cancer. JAMA 243:1635\u20131639.","journal-title":"JAMA"},{"key":"12_CR127","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archinte.1991.00400010089011","volume":"151","author":"WD DuPont","year":"1991","unstructured":"DuPont WD, Page DL. 1991. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 151:67\u201372.","journal-title":"Arch Intern Med"},{"key":"12_CR128","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.1991.03460150089030","volume":"265","author":"KK Steinberg","year":"1991","unstructured":"Steinberg KK, Thacker SB, Smith SJ, et al. 1991. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 265:1985\u20131990.","journal-title":"JAMA"},{"key":"12_CR129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5694\/j.1326-5377.1988.tb99424.x","volume":"148","author":"BK Armstrong","year":"1988","unstructured":"Armstrong BK. 1988. Oestrogen therapy after the menopause -- boon or bane? Med J Aust 148:213\u2013214.","journal-title":"Med J Aust"},{"key":"12_CR130","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/oxfordjournals.aje.a116043","volume":"134","author":"D Grady","year":"1991","unstructured":"Grady D, Ernster V. 1991. Invited commentary: does postmenopausal hormone therapy cause breast cancer? Am J Epidemiol 134:1396\u20131400.","journal-title":"Am J Epidemiol"},{"key":"12_CR131","first-page":"286","volume":"79","author":"M Sillero-Arenas","year":"1992","unstructured":"Sillero-Arenas M, Delgado-Rodriguez M, Rodrigues-Canteras R, et al. 1992. Menopausal hormone replacement therapy and breast cancer; a meta-analysis. Obstet Gynecol 79:286\u2013294.","journal-title":"Obstet Gynecol"},{"key":"12_CR132","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0002-9378(11)90784-4","volume":"168","author":"GA Colditz","year":"1993","unstructured":"Colditz GA, Egan KM, Stampfer MJ. 1993. Hormone replacement therapy and risk of breast cancer; results from epidemilogic studies. Am J Obstet Gynecol 168:1473\u20131480.","journal-title":"Am J Obstet Gynecol"},{"key":"12_CR133","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1001\/jama.1992.03490140108044","volume":"268","author":"JB Henrich","year":"1992","unstructured":"Henrich JB. 1992. The postmenopausal estrogen\/breast cancer controversy. JAMA 268:1900\u20131902.","journal-title":"JAMA"},{"key":"12_CR134","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1749-6632.1986.tb15998.x","volume":"464","author":"JHH Thijssen","year":"1986","unstructured":"Thijssen JHH, Van Landeghem AAJ, Poortman J. 1986. Uptake and concentration of steroid hormones in mammary tissues. Ann N Y Acad Sci 464:106\u2013116.","journal-title":"Ann N Y Acad Sci"},{"key":"12_CR135","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/jnci\/83.20.1450","volume":"83","author":"SG Nayfield","year":"1991","unstructured":"Nayfield SG, Karp JE, Ford LG, et al. 1991. Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 83:1450\u20131458.","journal-title":"J Natl Cancer Inst"},{"key":"12_CR136","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJM198608283150906","volume":"315","author":"HO Adami","year":"1986","unstructured":"Adami HO, Malker B, Holmberg L, et al. 1986. The relation between survival and age at diagnosis in breast cancer. N Engl J Med 315:559\u2013563.","journal-title":"N Engl J Med"},{"key":"12_CR137","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJM198703193161214","volume":"316","author":"HO Adami","year":"1987","unstructured":"Adami HO, Holmberg L, Malker B, et al. 1987. Letter. N Engl J Med 316:752.","journal-title":"Letter. N Engl J Med"},{"key":"12_CR138","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archinte.1991.00400010095012","volume":"151","author":"BE Henderson","year":"1991","unstructured":"Henderson BE, Paganini-Hill A, Ross RK. 1991. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 151:75\u201378.","journal-title":"Arch Intern Med"},{"key":"12_CR139","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/oxfordjournals.aje.a115008","volume":"128","author":"MH Criqui","year":"1988","unstructured":"Criqui MH, Suarez L, Barrett-Connor E, et al. 1988. Postmenopausal estrogen use and mortality. Am J Epidemiol 128:606\u2013614.","journal-title":"Am J Epidemiol"},{"key":"12_CR140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0002-9378(84)80002-2","volume":"150","author":"DR Gambrell","year":"1984","unstructured":"Gambrell DR. 1984. Proposal to decrease the risk and improve the prognosis in breast cancer. Am J Obstet Gynecol 150:119\u2013128.","journal-title":"Am J Obstet Gynecol"},{"key":"12_CR141","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJM199506153322401","volume":"332","author":"GA Colditz","year":"1995","unstructured":"Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE. 1995. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332:1589\u20131593.","journal-title":"N Engl J Med"},{"key":"12_CR142","first-page":"359","volume":"42","author":"TL Dao","year":"1982","unstructured":"Dao TL, Sinha DI, Nemoto T, Patel J. 1982. Effect of estrogen and progesterone on cellular replication of human breast tumors. Cancer Res 42:359\u2013362.","journal-title":"Cancer Res"},{"key":"12_CR143","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/1097-0142(19950101)75:1<43::AID-CNCR2820750109>3.0.CO;2-#","volume":"75","author":"MV Dhodapkar","year":"1995","unstructured":"Dhodapkar MV, Ingle JN, Ahmann DL. 1995. Estrogen replacement therapy withdrawal and regression of metastatic breast cancer. Cancer 75:43\u201346.","journal-title":"Cancer"},{"key":"12_CR144","first-page":"4595","volume":"36","author":"M Lippman","year":"1976","unstructured":"Lippman M, Bolan G, Huff K. 1976. The effects of estrogens and antiestrogens on hormone responsive human breast cancer in long-term tissue culture. Cancer Res 36:4595\u20134601.","journal-title":"Cancer Res"},{"key":"12_CR145","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/bmj.1.5533.150","volume":"1","author":"BA Stoll","year":"1967","unstructured":"Stoll BA. 1967. Effect of Lyndiol, an oral contraceptive, on breast cancer. Br Med J 1:150\u2013153.","journal-title":"Br Med J"},{"key":"12_CR146","first-page":"58","volume":"10","author":"AG Wile","year":"1991","unstructured":"Wile AG, Opfell DA, Hoda AC. 1991. Hormone replacement therapy does not affect breast cancer outcome. Proc Am Soc Clin Oncol 10:58.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"12_CR147","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0002-9610(05)80848-7","volume":"165","author":"AG Wile","year":"1993","unstructured":"Wile AG, Opfell RW, Margileth DA. 1993. Hormone replacement therapy in previously treated breast cancer patients. Am J Surg 165:372\u2013375.","journal-title":"Am J Surg"},{"key":"12_CR148","first-page":"67","volume":"2","author":"JA Eden","year":"1995","unstructured":"Eden JA, Bush T, Nand S, Wren BG. 1995. The Royal Hospital for Women Breast Cancer Study \u2014 a case\u2013controlled study of combined continuous hormone replacement therapy amongst women with a personal history of breast cancer. Menopause 2:67\u201372.","journal-title":"Menopause"},{"key":"12_CR149","first-page":"149","volume":"16","author":"RV Theriault","year":"1994","unstructured":"Theriault RV, Sellin RV. 1994. Estrogen-replacement therapy in younger women with breast cancer. Monogr Natl Cancer Inst (16):149\u2013152.","journal-title":"Monogr Natl Cancer Inst"}],"container-title":["Cancer Treatment and Research","Biological and Hormonal Therapies of Cancer"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-6189-7_12.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T21:21:39Z","timestamp":1637788899000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-6189-7_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998]]},"ISBN":["9781461378372","9781461561897"],"references-count":149,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-6189-7_12","relation":{},"ISSN":["0927-3042"],"issn-type":[{"type":"print","value":"0927-3042"}],"subject":[],"published":{"date-parts":[[1998]]}}}